Medicare Enrolled
Dr. Keval Shah, D.O.
Gastroenterology · Oxnard, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Keval Shah is a gastroenterology specialist in Oxnard, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 2,084 Medicare services across 1,472 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shah received a total of $10,866 from 45 pharmaceutical and/or device companies across 610 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 9% volume in CA
$10,866 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,084
Medicare services
Top 9% in CA for gastroenterology
1,472
Unique beneficiaries
$111
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~139 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
814 | $95 | $260 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
217 | $62 | $208 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
165 | $99 | $685 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
147 | $121 | $280 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
122 | $107 | $925 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
115 | $98 | $160 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
80 | $214 | $1,520 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
77 | $139 | $297 |
| External hemorrhoid removal by rubber banding A procedure to remove external hemorrhoids using rubber bands to cut off blood supply. The affected tissue is tied off and eventually falls off. |
63 | $240 | $700 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
52 | $78 | $240 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
50 | $143 | $320 |
| Liver stiffness measurement A non-invasive test that uses ultrasound or similar technology to measure the stiffness of liver tissue. This measurement helps assess the degree of liver fibrosis or scarring. |
31 | $25 | $100 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
30 | $10 | $86 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
23 | $173 | $320 |
| Endoscopy of digestive tract Imaging of the digestive tract performed from the inside using an endoscope. |
19 | $681 | $3,000 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
18 | $157 | $800 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
17 | $135 | $1,009 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
17 | $124 | $850 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
15 | $65 | $115 |
| New patient office visit, complex (60-74 min) | 12 | $167 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,866
Total received (2018-2024)
Avg $1,552/year across 7 years
Top 18% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
610
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,445 (96.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$422 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,577
2023
$1,899
2022
$1,959
2021
$1,140
2020
$1,520
2019
$819
2018
$953
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,052
Phathom Pharmaceuticals, Inc.
$233
AIMMUNE THERAPEUTICS, INC.
$169
QOL Medical, LLC
$161
Takeda Pharmaceuticals U.S.A., Inc.
$154
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$139
Janssen Biotech, Inc.
$127
Intercept Pharmaceuticals, Inc.
$91
PFIZER INC.
$72
Gilead Sciences, Inc.
$55
Madrigal Pharmaceuticals
$49
Regeneron Healthcare Solutions, Inc.
$46
Ardelyx, Inc.
$43
Organon Llc
$43
RedHill Biopharma Inc.
$26
Ipsen Biopharmaceuticals, Inc
$22
Enterra Medical, Inc.
$21
GENZYME CORPORATION
$21
Lilly USA, LLC
$19
Ferring Pharmaceuticals Inc.
$18
ALBIREO PHARMA, INC.
$14
Top 3 companies account for 56.5% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,972
AbbVie Inc.
$1,814
QOL Medical, LLC
$708
Takeda Pharmaceuticals U.S.A., Inc.
$700
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$696
Janssen Biotech, Inc.
$687
Ardelyx, Inc.
$529
PFIZER INC.
$480
Gilead Sciences, Inc.
$477
AbbVie, Inc.
$422
Phathom Pharmaceuticals, Inc.
$233
Intercept Pharmaceuticals, Inc.
$208
AIMMUNE THERAPEUTICS, INC.
$169
Ferring Pharmaceuticals Inc.
$156
Boston Scientific Corporation
$133
AstraZeneca Pharmaceuticals LP
$125
Celgene Corporation
$118
Nestle HealthCare Nutrition Inc.
$117
Regeneron Healthcare Solutions, Inc.
$114
Synergy Pharmaceuticals Inc
$98
GENZYME CORPORATION
$89
Braintree Laboratories, Inc.
$72
IRONWOOD PHARMACEUTICALS, INC
$71
Daiichi Sankyo Inc.
$57
NESTLE HEALTHCARE NUTRITION INC.
$56
Merck Sharp & Dohme LLC
$51
Madrigal Pharmaceuticals
$49
Medtronic, Inc.
$49
Merck Sharp & Dohme Corporation
$45
Prometheus Laboratories Inc.
$45
Organon Llc
$43
INTERCEPT PHARMACEUTICALS, INC.
$29
RedHill Biopharma Inc.
$26
Shire North American Group Inc
$25
Allergan Inc.
$24
Ironwood Pharmaceuticals, Inc
$23
Ipsen Biopharmaceuticals, Inc
$22
Enterra Medical, Inc.
$21
Shionogi Inc
$21
Covidien LP
$19
Lilly USA, LLC
$19
Ethicon US, LLC
$15
ALBIREO PHARMA, INC.
$14
EVOKE PHARMA, INC.
$13
Janssen Scientific Affairs, LLC
$13
Top 3 companies account for 41.4% of all-time payments
Associated products mentioned in payments ›
BRILINTA · Bylvay · CIMZIA · CREON · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · EOHILIA · EPIC BILIARY · Entyvio · GATTEX · GI GENIUS · GIMOTI · HADLIMA · HUMIRA · Humira · IBSRELA · INJECTAFER · LINX Reflux Management System · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mulpleta · OCALIVA · OMVOH · REBYOTA · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SIMPONI · SKYRIZI · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS TABLETS · VIBERZI · VOQUEZNA · VOWST · Vemlidy · WATCHMAN · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
27
Per 100K population
3.2
County median income
$107,327
Nearest hospital
ST JOHNS REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shah is a clinical cardiology specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement in the top 18% of CA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shah performed 814 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $10,866 from 45 companies across 610 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other gastroenterologists in Oxnard?
Dr. Shah's average Medicare payment per service is $111. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Oxnard
Browse gastroenterologists in Oxnard ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in CA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in CA
Which CA gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
QOL Medical, LLC Payments to Doctors
See all physicians who received payments from QOL Medical, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology